MedTrace Logo

Biomarkers in First Episode Schizophrenia

NCT02033382 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 165

Last updated 2021-01-14

Study results available
· View outcomes & findings →

Summary

This study will identify and evaluate relevant biomarkers and structural brain imaging for understanding potential biological illness related mechanisms in medication-naïve subjects with early psychosis before and after initiation of antipsychotic medication

Conditions

  • Schizophrenia
  • Schizophreniform Disorder
  • Schizoaffective Disorder, Depressed Type

Sponsors & Collaborators

Eligibility

Min Age
16 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02033382 on ClinicalTrials.gov